Virtual reality goggles could revolutionize MS mobility tests

NCT ID NCT07361965

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test whether mixed reality (using Meta Quest 3 goggles) can reliably measure walking, standing, and balance in 75 people with multiple sclerosis. Participants will perform standard mobility tests both conventionally and in a mixed reality environment. The goal is to see if the digital version is as accurate and useful as traditional methods, potentially paving the way for remote assessments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mixed reality-based functional mobility tests using Meta Quest 3
What this could lead to
If successful, this could provide a more objective and engaging way to assess mobility in MS, potentially enabling remote monitoring.
What could go wrong
This is a small, early-stage validity study, not a treatment trial. The technology may not prove reliable or practical for widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 75 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Individuals with MS who applied to the Selçuk University Faculty of Medicine Hospital MS Living Center

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * A confirmed diagnosis of multiple sclerosis (MS) established by a neurologist, * Not being in a relapse phase and having no MS relapse within the past 6 months, * Aged between 18 and 60 years, * Disease severity within an Expanded Disability Status Scale (EDSS) range of 1-5 (mild to moderate functional impairment), * Visual, auditory, and vestibular functions sufficient to tolerate mixed reality-based applications, * Adequate cognitive capacity to actively participate in the study (e.g., Mini-Mental State Examination score ≥ 24), * Ability to read, understand, and follow instructions in Turkish, * Willingness to participate voluntarily in the study and provision of written informed consent. Exclusion Criteria: * Having experienced a multiple sclerosis relapse or undergone a change in MS-related treatment within the past 6 months, * Presence of severe musculoskeletal disorders (e.g., fracture, arthritis, advanced osteoarthritis, muscle tear) that may interfere with test performance, * Presence of severe cardiopulmonary disease (e.g., uncontrolled hypertension, heart failure, chronic obstructive pulmonary disease) or any medical condition that may pose a risk during exercise testing, * Risk of loss of balance or spatial disorientation in the mixed reality environment due to visual, vestibular, or auditory impairments, * Inability to perform functional tests due to severe spasticity, contractures, or orthopedic deformities, * History of epilepsy, migraine, or other neurological conditions that contraindicate the use of mixed reality or virtual reality devices, * Inability to understand test instructions due to cognitive impairment or severe mental health disorders (e.g., dementia, major depression, psychotic disorders), * Experiencing dizziness, nausea, or virtual reality-related symptoms (VR sickness) during testing, * Insufficient motivation or poor compliance that may hinder participation in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mixed reality are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Selcuk University Faculty of Medicine Hospital MS Life Center

    Konya, Selcuklu, 42130, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.